Skip to main content
. 2003 Jan;47(1):118–123. doi: 10.1128/AAC.47.1.118-123.2003

FIG. 1.

FIG. 1.

Individual amprenavir (A) and ritonavir (B) concentration-time profiles for patients who received amprenavir at 600 mg BID plus ritonavir at 100 mg BID with (dotted lines) or without (solid lines) efavirenz at 600 mg once daily. APV, amprenavir; RTV; ritonavir; EFV, efavirenz.